Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,306,537
+$19,816,443 QoQ
Shares Held
1,095,881
+117.5% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Divisadero Street Capital Management, LP holds $70,880,934 across 7 Medical Devices names. AXGN ranks #1 (51.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXGN |
Axogen, Inc.
This page
|
1,095,881 | $36,306,537 | |
| 2 | PRCT |
PROCEPT BioRobotics Corp
|
866,338 | $21,667,113 | |
| 3 | TCMD |
Tactile Systems Technology Inc
|
237,884 | $6,215,908 | |
| 4 | DCTH |
Delcath Systems, Inc.
|
499,796 | $4,638,106 | |
| 5 | SRTS |
Sensus Healthcare, Inc.
|
286,078 | $1,138,590 | |
| 6 | INGN |
Inogen Inc
|
88,136 | $544,680 | |
| 7 | RCEL |
AVITA Medical, Inc.
|
100,000 | $370,000 |
All Filings in AXGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,306,537 | 1,095,881 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,490,094 | 503,822 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $468,692 | 26,272 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $285,051 | 26,272 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $486,032 | 26,272 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $444,498 | 26,972 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $368,333 | 26,272 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,973,836 | 686,994 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $806,757 | 99,970 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $313,968 | 45,969 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||